ARGX-124

N/A

Report date: 2026/03/07 20:00:27
First In Class

Base Information

Drug NameARGX-124
Drug Alias NameARGX-124ARGX124
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionIgG receptor FcRn large subunit p51 modulators
TargetsIgG receptor FcRn large subunit p51
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArgenx Se
China Registration ClassN/A

Develop Information

Active CompaniesArgenx Se
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A